Literature DB >> 7377324

Evaluation of long-term chemical sympathectomy in adult rabbits.

K Fronek.   

Abstract

Administration of 6-hydroxydopamine (6-OHDA) will produce long-term sympathectomy in newborn animals. This investigation was designed to determine whether or not a long-term sympathectomy can be achieved by repeated administration of 6-OHDA in adult rabbits. Chronic treatment with 6-OHDA lowered blood pressure on average of 9 mmHg; the carotid sinus reflex was depressed, in contrast to the pressure response to intravenously administered epinephrine, which was doubled. In a constant-flow hindlimb preparation, the response to norepinephrine (NE) in 6-OHDA-treated rats was 50% larger and lasted 3 times longer. NE uptake in vitro, which is proportional to the number of adrenergic nerve endings, was found to be diminished by 80-85% in aortas from 6-OHDA-treated animals, and the dose-response curve for NE was slightly shifted to the left. The number of ganglionic cells in the superior cervical ganglia in treated animals was decreased by 80%. In conclusion, results from 6-OHDA-treated adult animals were entirely consistent with the effects of long-term sympathectomy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7377324     DOI: 10.1152/ajpheart.1980.238.4.H527

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Trophic effect of the sympathetic nervous system on vascular smooth muscle.

Authors:  K Fronek
Journal:  Ann Biomed Eng       Date:  1983       Impact factor: 3.934

2.  Tracer norepinephrine kinetics in coronary circulation of patients with heart failure secondary to chronic pressure and volume overload.

Authors:  C P Rose; J H Burgess; D Cousineau
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

3.  Effects of chemical denervation with 6-hydroxydopamine on myocardial responsiveness to isoproterenol in rabbits.

Authors:  J Tse; E Rodriquez; M Gonzalez; H R Weiss
Journal:  Basic Res Cardiol       Date:  1995 Sep-Oct       Impact factor: 17.165

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.